Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Inter Parfums (IPAR)

Interparfums Q3 sales rise 15% to $425 million; diluted EPS up 16% to $1.93

Positive Impact 3 of 5 earnings Written later

Interparfums reported third-quarter 2024 net sales of $425 million, up 15%, with operating income up 22% to $106 million and diluted EPS of $1.93 versus $1.66 a year earlier. The company reaffirmed its 2024 guidance of $1.45 billion in net sales and $5.15 diluted EPS, and said initial 2025 guidance will come on November 12, 2024.

Key points

  • Q3 2024 net sales were $425 million, up 15% from $368 million; nine-month net sales were $1.09 billion, up 10%.
  • Q3 diluted EPS was $1.93, up from $1.66; nine-month diluted EPS was $4.34, down 2% from $4.42.
  • Operating cash flow for Q3 was $76.1 million, compared with $17.5 million in the prior-year quarter.
  • The regular quarterly dividend of $0.75 per share is payable December 31, 2024, to holders of record on December 16, 2024.

The filing

CompanyInter Parfums (IPAR)
Form8-K, current report
Filed with the SECNov 6, 2024, 4:34 PM ET
Accession number0001753926-24-001820

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:00 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.